Literature DB >> 3893255

Captopril-induced renal insufficiency and the role of sodium balance.

D E Hricik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3893255     DOI： 10.7326/0003-4819-103-2-222

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  ACE inhibitors in renovascular hypertension.

Authors:  S C Textor
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

2.  Reversible impairment of renal function associated with enalapril in a diabetic patient.

Authors:  M M Albareda; R Corcoy
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

3.  Adverse effects of captopril in hospital outpatients with hypertension.

Authors:  T Walley; P Winstanley; D Roberts; M Grimmer; M Orme; A Breckenridge
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

Review 4.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 5.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 6.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 7.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.